K-beauty hit the US market with a compelling argument: Korean women have the world’s most meticulous skincare routines, and here’s the proof stacked on shelves at Sephora, Target, and a hundred Amazon storefronts. By most industry estimates, the US market for Korean beauty products now exceeds $2 billion in annual sales. Fermented essences, snail secretion serums, and high-concentration niacinamide ampoules sit next to domestic brands without a whisper of explanation about how they got there — or who checked that they were safe before they did.
What nobody mentions in those haul videos: the regulatory framework that cleared those products in Korea has almost nothing to do with FDA oversight. And the EU — widely held up as the gold standard for cosmetic safety — restricts or bans roughly 1,400 cosmetic ingredients that are still perfectly legal to sell in the US.
Those two facts together say something important about what “safe” actually means in the beauty aisle.
Why “Approved in Korea” Doesn’t Mean What Most Shoppers Assume
Korea’s Ministry of Food and Drug Safety (MFDS) operates a genuinely rigorous system — specifically for what they call “functional cosmetics.” Products that make claims around brightening (reducing melanin production), anti-wrinkle, or UV protection fall into this category. Under the Korean Cosmetics Act, these functional categories require MFDS review and clinical substantiation before a brand can make those claims on packaging.
That sounds reassuring until you understand how the FDA interprets the same products. What the MFDS classifies as a functional cosmetic, the FDA would likely classify as a drug — because it’s making structure/function claims about altering how the body works. An ampoule that claims to “inhibit melanin biosynthesis” is, in the FDA’s framework, describing a drug effect. Drugs require pre-market approval. Cosmetics, historically, did not.
In practice, this means K-beauty brightening ampoules, retinol-heavy “youth” serums, and anti-wrinkle actives often land in a US regulatory gray zone. They haven’t gone through FDA’s drug approval process. But they also haven’t undergone any formal US cosmetic safety review — because the system didn’t require one until very recently.
The Federal Food, Drug, and Cosmetic Act — the law governing cosmetics — was first written in 1938. For most of its life, brands could bring a cosmetic to market in the US without registering with the FDA, without safety testing documentation, and without notifying anyone. The Modernization of Cosmetics Regulation Act (MoCRA), signed in December 2022, changed some of that. But MoCRA is still being phased in, and the agency is still building the infrastructure to enforce it at scale.
The EU Number That Should Change How You Read Labels
Here’s the statistic worth sitting with: the EU’s Cosmetics Regulation (EC No 1223/2009) prohibits or restricts approximately 1,400 substances across its Annexes II and III. The FDA’s list of prohibited and restricted cosmetic ingredients has historically contained roughly 11 substances — mercury compounds, bithionol, vinyl chloride, and a handful of others.
Eleven versus fourteen hundred.
To be fair, this comparison isn’t perfectly apples-to-apples. The EU operates on a precautionary principle that some toxicologists argue over-restricts ingredients with solid safety data. And not every ingredient on the EU’s restricted list is genuinely dangerous at typical use levels. But the gap does tell you something meaningful about the floor that European-formulated products were built to meet — versus the floor that US-sold products, including imports, have been held to.
Some specific differences that actually matter day-to-day:
Fragrance labeling. EU regulations require 26 specific fragrance allergens to be individually named on cosmetic labels when they exceed certain concentration thresholds. In the US, “fragrance” or “parfum” can appear as a single ingredient entry, legally concealing potentially hundreds of individual compounds — including common contact allergens. If you’ve ever had an unexplained skin reaction to a product you otherwise like, fragrance masking is frequently the reason you can’t identify the culprit.
Parabens. The EU restricts five specific parabens — including isopropylparaben and isobutylparaben — from cosmetic formulations over concerns about endocrine disruption. The FDA has reviewed the data and, as of 2026, has not issued equivalent restrictions. Many US and K-beauty products still contain these compounds in leave-on formulations.
Kojic acid. A fixture in K-beauty brightening serums. The EU caps its use in leave-on face products at a 1% maximum concentration due to skin sensitization data. No equivalent US limit exists. You’ll find K-beauty products with kojic acid at concentrations well above that threshold sold freely in the US.
What This Actually Means When You’re Shopping
None of this is a reason to clear your bathroom shelf. Korean manufacturers like COSRX, Anua, and Missha are sophisticated formulators working within a real regulatory system. And most of what people are buying — hydrating toners, ceramide moisturizers, gentle cleansers with established ingredient profiles — uses compounds with decades of safety data. The concern isn’t that K-beauty is categorically risky. It’s that the US doesn’t require any additional safety review for imported cosmetics before they reach consumers.
Under MoCRA, domestic and foreign facilities that manufacture cosmetics for US distribution must now register with the FDA and list their products. Domestic manufacturers had until December 2023 to comply; foreign manufacturers have a phased-in timeline extending further. But — and this is the part that gets glossed over — registration isn’t a safety substantiation review. It’s record-keeping. The FDA knows your facility exists. It hasn’t necessarily reviewed your formulations.
So what can you actually do with this information?
Check active-ingredient products more carefully than your basics. Functional-category K-beauty — brightening ampoules, high-percentage retinol derivatives, exfoliating acids, exosome serums — are the products most likely to sit in regulatory gray zones. These are worth researching before you commit.
Read the full ingredient list, not just the marketing claims. Tools like EWG’s Skin Deep database and CosDNA (designed specifically for K-beauty ingredient analysis) let you flag potential sensitizers and allergens faster than reading the literature yourself. Neither is a perfect oracle, but both beat trusting front-of-pack language.
Ask whether the brand has US-market safety documentation. Some Korean brands serious about the US market have pursued third-party testing or NSF International certification for their product lines. Most haven’t. If a brand can’t point you to any independent safety substantiation, that’s worth factoring into your decision.
Treat “whitening” and anti-aging categories with more skepticism. These push the highest active concentrations and are where ingredient safety margins matter most. They’re also where the gap between Korean regulatory oversight and US oversight is widest.
MoCRA Changed the Rules — Just Not All of Them Yet
MoCRA is a genuine turning point for US cosmetic regulation. For the first time in history, the FDA can order mandatory recalls of unsafe cosmetics — previously it could only request voluntary ones, which companies could decline. The law requires GMP (good manufacturing practice) standards for cosmetic facilities, mandates adverse event reporting for serious incidents, and introduces allergen labeling requirements for fragrance compounds. These are real improvements.
But implementation is incremental, and the FDA is an enormous agency stretched across many priority areas. Cosmetics aren’t drugs or medical devices; they don’t get the same resource allocation. Foreign manufacturers are still in early compliance windows. And the fundamental architecture of US cosmetics oversight — pre-market safety review is still not required the way it is in the EU — hasn’t changed.
The practical reality for most US shoppers is this: until MoCRA is fully operational and foreign manufacturers are consistently in compliance, the cosmetics market still runs substantially on post-market safety data. Products reach shelves before anyone has independently verified they’re safe for the consumer buying them.
That’s not unique to K-beauty. It’s true of domestic brands too. The point isn’t to single out one country’s products — it’s to understand that “sold in the US” has never been a guarantee of any particular safety standard.
The comparison that actually matters isn’t whether your product is Korean, European, or domestic. It’s: what standard was this product actually held to, and by whom? The country of origin doesn’t answer that question on its own. The brand’s willingness to show you testing data does.
That’s the part the haul videos skip.
Written by Nour Abochama, Host & Quality Control Expert, Nourify & Beautify. Learn more about our team
Have questions about product safety? Talk to our experts Contact us
Related from our network
- Cosmetic Ingredient Testing and Heavy Metals Screening — Qalitex Laboratories provides ISO 17025-accredited testing for cosmetic products, including contaminant screening and ingredient verification for US market compliance.
- Raw Material Identity and Supplier Qualification Testing — Ayah Labs offers COA verification and purity testing for cosmetic raw materials and active ingredients sourced internationally.
